Question
What will Safe Superintelligence Inc.'s (SSI) most recently reported valuation be as of December 31, 2027, in USD billions? Use the post-money valuation of the latest priced or strategic round publicly reported by that date.
Current Anchor and Resolution Rules: The resolution depends on the latest publicly reported post-money valuation of a priced or strategic round for Safe Superintelligence (SSI) by the end of 2027. Currently, SSI's last officially disclosed valuation is $32B from its roughly $2B April 2025 round. Nvidia announced a strategic investment in July 2026—widely reported at $5B—but neither company disclosed a valuation for the transaction Ilya Sutskever's Safe Superintelligence Inc. and NVIDIA ... Ilya Sutskever's Safe Superintelligence Inc. and NVIDIA ... Nvidia to invest $5 billion in Ilya Sutskever's AI startup .... If no subsequent priced or strategic round is reported, the answer will fall back to any later disclosure of the Nvidia deal's valuation, or if none appears, the $32B mark.
Likelihood of a New Reported Valuation: SSI is a highly secretive lab focused on a "straight-shot" to superintelligence with no planned product cycles Safe Superintelligence Inc., which could insulate it from the typical pace of commercial fundraising Ilya Sutskever — We're moving from the age of scaling to the age of research. However, Nvidia’s investment grants SSI access to Vera Rubin systems to increase its compute capacity tenfold within a year This AI startup has roughly 50 employees, no product and ... Ilya Sutskever on X: "Time to scale that SSI:" / X. Running infrastructure at this frontier scale costs billions annually, meaning SSI’s roughly $8B in total funding creates substantial pressure to raise again before the end of 2027. Nevertheless, the substantial likelihood of prolonged secrecy and delayed mega-rounds across related labs means that funding pressure need not translate into a publicly reported valuation by the deadline. I assign roughly a 60% probability that a new round (or the Nvidia deal's valuation) is publicly reported before the deadline, and about a 40% chance that the answer defaults to the $32B anchor due to either a lack of new fundraising or SSI maintaining its strict secrecy regarding deal terms Ilya Sutskever's Safe Superintelligence raises $5 billion from ... Ilya Sutskever: The 100 Most Influential People in AI 2026.
Benchmarking a Future Round: If a new round is reported, it will likely represent a significant up-round. Peer labs have seen steep step-ups: DeepSeek raised at a ~$74B pre-money valuation, Thinking Machines has been in talks at a $40B+ pre-money mark, and Discovery Loop has reportedly sought ~$50B. Furthermore, accelerating AI research capabilities and the increasing necessity of immense compute clusters create an environment where frontier labs like OpenAI and Anthropic are clearing trillion-dollar marks. Given CEO Ilya Sutskever's reputation and Nvidia's private research access and strategic backing Ilya Sutskever's Safe Superintelligence Inc. and NVIDIA ..., a conditional median for a new round lands near $90B–$100B. A more modest outcome could emerge if the Nvidia deal’s valuation simply leaks at around $40B–$50B. With substantial probability concentrated at the $32B fallback, and delayed mega-rounds leaving room for only a modest valuation disclosure, the overall median lands at $45B rather than near the conditional median for a new round.
Downside Risks and the Upper Tail: The resulting distribution exhibits a sticky lower tail and a long right tail. The p10 and p25 estimates remain tightly bound to the $32B fallback, reflecting the substantial probability that no new valuation surfaces. Downward pressure on a new round could stem from recent market stress—such as the Nasdaq's November 2026 volatility and the sudden resignation of Nvidia's CEO Neoclouds, AI stocks slide again as Nvidia turmoil rattles ...—or if SSI's lack of publicly shipped models dampens investor appetite. Conversely, the upper tail captures scenarios where SSI convincingly demonstrates private breakthroughs, unlocking strategic scarcity premiums that push a new valuation into the $150B–$250B range. I place the 75th percentile at $90B and the 90th percentile at $150B: substantial up-rounds remain plausible, but the most ambitious valuations require both research progress and a disclosed transaction before the deadline.
Incorporating a substantial likelihood of prolonged secrecy and delayed mega-rounds modeled across related labs, the median valuation was reduced from $51.7B to $45.0B.
Ask a followup
Sign in to run · $20 free credit, no card · every claim cited